IMARC
Biopsy Devices Market Growth 2024-2032, Industry Size, Share, Trends and Forecast

Biopsy Devices Market Growth 2024-2032, Industry Size, Share, Trends and Forecast

Suraj Singh's photo
Suraj Singh
·

4 min read

The latest report by IMARC Group, titled “Biopsy Devices Market Report by Procedure Type (Surgical Biopsy, Needle Biopsy), Product (Biopsy Guidance Systems, Needle Based Biopsy Guns, Biopsy Needles, Biopsy Forceps, and Others), Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, and Others), Guidance Technique (Ultrasound Guided Biopsy, Stereotactic Guided Biopsy, MRI Guided Biopsy, and Others), End User (Hospitals and Clinics, Academic and Research Institutes, and Others), and Region 2024-2032“, The global biopsy devices market size reached USD 2.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach USD 4.4 Billion by 2032, exhibiting a growth rate (CAGR) of 5.8% during 2024-2032.

Biopsy instruments are crucial in the realm of medical diagnosis and health care. These specialized devices are employed by medical professionals to obtain tissue samples from different areas of the human body for additional examination. Biopsy techniques are essential in identifying and evaluating the presence of ailments, including cancer, infections, and various other medical issues. These tools are engineered to guarantee minimal invasiveness while retrieving precise tissue samples, rendering them an essential element of the healthcare system.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/biopsy-devices-market/requestsample

Biopsy Devices Market Trends and Drivers:

A key factor contributing to market growth is the rising incidence of cancer and other chronic illnesses around the globe. As cancer cases continue to increase, the need for biopsy procedures and instruments has escalated. Healthcare professionals are depending on biopsy tools to gather tissue samples that are vital for precise cancer diagnosis, staging, and treatment strategies. This heightened need for biopsy equipment is anticipated to drive market growth in the upcoming years. Another significant trend in the worldwide biopsy devices sector is the ongoing innovation and progress in biopsy technology. Manufacturers are persistently working to create more efficient and user-friendly devices. This includes the incorporation of features such as real-time imaging and guidance systems, which improve the precision and accuracy of biopsy procedures. Furthermore, the emergence of minimally invasive biopsy methods, like fine-needle aspiration and core needle biopsy, has gained traction. These methods lessen patient discomfort, minimize recovery periods, and reduce healthcare expenses, thereby encouraging the use of biopsy devices. Additionally, regulatory initiatives and approvals are vital in shaping the global biopsy devices market. Governments and regulatory bodies are concentrating on simplifying the approval process for new biopsy instruments while ensuring their safety and effectiveness. This regulatory backing offers manufacturers a clear route to market entry, promoting competition and innovation within the industry, and consequently driving market growth.

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Procedure Type:

  • Surgical Biopsy

  • Needle Biopsy

Breakup by Product:

  • Biopsy Guidance Systems

  • Needle Based Biopsy Guns

  • Biopsy Needles

  • Biopsy Forceps

  • Others

Breakup by Application:

  • Breast Biopsy

  • Lung Biopsy

  • Colorectal Biopsy

  • Prostate Biopsy

  • Others

Breakup by Guidance Technique:

  • Ultrasound Guided Biopsy

  • Stereotactic Guided Biopsy

  • MRI Guided Biopsy

  • Others

Breakup by End User:

  • Hospitals and Clinics

  • Academic and Research Institutes

  • Others

Market Breakup by Region:

  • North America (United States, Canada)

  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)

  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

  • Latin America (Brazil, Mexico, Others)

  • Middle East and Africa

Competitive Landscape with Key Player:

  • Argon Medical Devices

  • Becton Dickinson and Company

  • Boston Scientific Corporation

  • Cardinal Health Inc.

  • CONMED Corporation

  • Cook Group Incorporated

  • Hologic Inc.

  • INRAD Inc.

  • Medtronic plc

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

**About Us:

**IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.